Guardant Health stock has had several attempts at breaking out of a cup base. The company has a blood test to detect colon ...

Colorectal cancer is the second leading cause of cancer-related deaths for males and females. Screening for colorectal cancer ...

A new Galleri blood test detected 75% of cancers without current screening options, with over half found in early stage I or ...

Among nearly 25 million privately insured adults, significant shifts in colorectal cancer (CRC) screening practices were identified after the onset of COVID-19. 1 Between 2017 and 2024, colonoscopy ...

Standard cancer screenings in the U.S. overlook nearly 70% of cancers and cancer subtypes. Multiple-cancer early detection (MCED) blood tests can help identify cancer biomarkers for multiple cancer ...

Cancer doesn’t discriminate, but Black men in particular have to deal with an increased risk Black men face for ...

New ‘concerning’ data find that most US endoscopists aren’t following current polypectomy guidelines for polyps < 1 cm, ...

Rising early-onset cancer incidence has become a growing concern, but rates also have increased among individuals aged 50 years and older for many of the same malignancies.An international ...

Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells – hard-to-find cells that help cancers spread, come back after treatment and resist ...

Breast cancer remains one of the leading causes of death among women in Jamaica, a stark reality that underscores the urgency ...

While Natera said it will seek FDA approval for Signatera based on data from IMvigor011, the readout from another ctDNA-guided de-escalation study was more nuanced.